SAKK – YOUNG ONCOLOGY ACADEMY - Was junge Onkologen von ESMO - EHA - ESTRO und ESP berichten — European Society for Medical Oncology (ESMO) Congress 2024
PD-1 Blockade in early Endometrial and Cervical Cancers
At this year’s ESMO 2024 annual meeting, two pivotal phase 3 trials investigating pembrolizumab in advanced non-metastatic gynecologic cancers were presented, potentially changing the treatment landscape in both cervical and endometrial cancer.